Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules
- PMID: 9045682
- DOI: 10.1074/jbc.272.10.6556
Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules
Abstract
The Jak1, Jak2, Jak3, and Fes tyrosine kinases have been demonstrated to undergo tyrosine phosphorylation in response to interleukin (IL)-4 stimulation in different cell systems. However, it is not clear which, if any, of these kinases are responsible for initiating IL-4-induced tyrosine phosphorylation of intracellular substrates in vivo. In the present study, we have utilized a mutant Jak1-deficient HeLa cell line, E1C3, and its parental Jak1-expressing counterpart, 1D4, to analyze the role of Jak1 in mediating IL-4-induced tyrosine phosphorylation events. IL-4 treatment rapidly induced tyrosine phosphorylation of insulin receptor substrate (IRS)-1 and IRS-2 in 1D4 but not in E1C3 cells. IL-4-mediated tyrosine phosphorylation of Stat6 was pronounced in 1D4 cells, while no IL-4-induced Stat6 phosphorylation was detected in E1C3 cells. IL-4 also induced Stat6 DNA binding activity from lysates of 1D4 but not E1C3 cells utilizing a radiolabeled immunoglobulin heavy chain germline epsilon promotor sequence (Iepsilon) in an electrophoretic mobility shift assay. Reconstitution of Jak1 expression in E1C3 cells restored the ability of IL-4 to induce IRS and Stat6 tyrosine phosphorylation. These results provide evidence that Jak1 expression is required for mediating tyrosine phosphorylation and activation of crucial molecules involved in IL-4 signal transduction.
Similar articles
-
The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells.J Immunol. 1997 Feb 1;158(3):1037-40. J Immunol. 1997. PMID: 9013940
-
Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.Blood. 2000 Jan 15;95(2):494-502. Blood. 2000. PMID: 10627454
-
Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts.J Biol Chem. 1996 Sep 6;271(36):22175-82. doi: 10.1074/jbc.271.36.22175. J Biol Chem. 1996. PMID: 8703030
-
Signal transduction through the IL-4 and insulin receptor families.Stem Cells. 1995 Jul;13(4):360-8. doi: 10.1002/stem.5530130407. Stem Cells. 1995. PMID: 7549895 Review.
-
IL-4/IL-13 signaling beyond JAK/STAT.J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1063-70. doi: 10.1067/mai.2000.107604. J Allergy Clin Immunol. 2000. PMID: 10856136 Review.
Cited by
-
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.Front Immunol. 2021 Jun 25;12:695815. doi: 10.3389/fimmu.2021.695815. eCollection 2021. Front Immunol. 2021. PMID: 34305932 Free PMC article. Review.
-
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future.Biomolecules. 2020 Jul 5;10(7):1002. doi: 10.3390/biom10071002. Biomolecules. 2020. PMID: 32635659 Free PMC article. Review.
-
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines.Front Immunol. 2019 Feb 20;10:263. doi: 10.3389/fimmu.2019.00263. eCollection 2019. Front Immunol. 2019. PMID: 30842774 Free PMC article. Review.
-
IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View.Front Immunol. 2018 May 15;9:1037. doi: 10.3389/fimmu.2018.01037. eCollection 2018. Front Immunol. 2018. PMID: 29868002 Free PMC article. Review.
-
1,6-O,O-Diacetylbritannilactone Inhibits Eotaxin-1 and ALOX15 Expression Through Inactivation of STAT6 in A549 Cells.Inflammation. 2017 Dec;40(6):1967-1974. doi: 10.1007/s10753-017-0637-y. Inflammation. 2017. PMID: 28770377
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
